In brief, latency 0 is typically found in resting PBMC B-cells with the most restricted gene expression (only EBNA1 and BARTs expressed) [13,14]; latency I (EBNA1, BARTs, LMP2A expressed) is found in BL [15] and gastric cancer [16,17,18]; while latency II (EBNA1, BARTs, LMP1, LMP2A, 2B expressed) has been reported in multiple types of EBV-associated carcinomas and lymphomas [3,5,19]; and finally, latency III (Cp, all EBNAs, BARTs, LMP1, LMP2A, 2B expressed) is mostly found in B-cell malignancies in immunocompromised cases [1,2,3]. Here, PDLIM7 is linked to lymphoma.